JM2 Capital’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$363K Buy
2,548
+174
+7% +$26.4K 0.24% 84
2026
Q2
$372K Sell
2,374
-207
-8% -$31K 0.26% 87
2026
Q1
$394K Buy
2,581
+34
+1% +$5.21K 0.33% 76
2025
Q4
$351K Buy
+2,547
New +$334K 0.28% 82

Other funds holding NVS

JM2 Capital's NVS Position: Q3 2026 in Review

JM2 Capital increased its Novartis (NVS) stake by 7.3% in Q3 2026, buying an estimated $26.4K and bringing the position to 2,548 shares worth $363K. The position accounts for 0.24% of the portfolio, ranked #84.

JM2 Capital first reported a position in NVS in Q4 2025 and has held it in 4 quarters since. The position peaked at $394K in Q1 2026. 1,561 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • JM2 Capital held 2,548 shares of Novartis worth $363K as of Q3 2026.
  • JM2 Capital bought 174 Novartis shares in Q3 2026, an estimated $26.4K.
  • Novartis made up 0.24% of JM2 Capital's portfolio in Q3 2026, its #84 holding.
  • JM2 Capital first reported a position in Novartis in Q4 2025 and has held it in 4 quarters since.
  • JM2 Capital's Novartis position peaked at $394K in Q1 2026.
  • 1,561 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on JM2 Capital's 13F filing for Q3 2026, filed 14 Oct 2026.